Literature DB >> 18197612

Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.

Ariamala Gopalsamy1, Mengxiao Shi, Jennifer Golas, Erik Vogan, Jaison Jacob, Mark Johnson, Frederick Lee, Ramaswamy Nilakantan, Roseann Petersen, Kristin Svenson, Rajiv Chopra, May S Tam, Yingxia Wen, John Ellingboe, Kim Arndt, Frank Boschelli.   

Abstract

Heat shock protein 90 (Hsp90) is a molecular chaperone that is responsible for activating many signaling proteins and is a promising target in tumor biology. We have identified small-molecule benzisoxazole derivatives as Hsp90 inhibitors. Crystallographic studies show that these compounds bind in the ATP binding pocket interacting with the Asp93. Structure based optimization led to the identification of potent analogues, such as 13, with good biochemical profiles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197612     DOI: 10.1021/jm701385c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

2.  Computational polypharmacology analysis of the heat shock protein 90 interactome.

Authors:  Andrew Anighoro; Dagmar Stumpfe; Kathrin Heikamp; Kristin Beebe; Leonard M Neckers; Jürgen Bajorath; Giulio Rastelli
Journal:  J Chem Inf Model       Date:  2015-02-23       Impact factor: 4.956

3.  Synthesis of 2-(2,4-dihydroxyphenyl)thieno-1,3-thiazin-4-ones, their lipophilicity and anticancer activity in vitro.

Authors:  Joanna Matysiak; Małgorzata Juszczak; Monika M Karpińska; Ewa Langner; Katarzyna Walczak; Marta K Lemieszek; Alicja Skrzypek; Andrzej Niewiadomy; Wojciech Rzeski
Journal:  Mol Divers       Date:  2015-04-29       Impact factor: 2.943

4.  Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitors.

Authors:  Mahmoud A Al-Sha'er; Mutasem O Taha
Journal:  J Mol Model       Date:  2012-06-16       Impact factor: 1.810

5.  Synthesis of benzisoxazoles by the [3 + 2] cycloaddition of in situ generated nitrile oxides and arynes.

Authors:  Anton V Dubrovskiy; Richard C Larock
Journal:  Org Lett       Date:  2010-03-19       Impact factor: 6.005

6.  Solution-phase synthesis of a diverse library of benzisoxazoles utilizing the [3 + 2] cycloaddition of in situ-generated nitrile oxides and arynes.

Authors:  Anton V Dubrovskiy; Prashi Jain; Feng Shi; Gerald H Lushington; Conrad Santini; Patrick Porubsky; Richard C Larock
Journal:  ACS Comb Sci       Date:  2013-03-08       Impact factor: 3.784

7.  Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assay.

Authors:  Thota Ganesh; Pahk Thepchatri; Lian Li; Yuhong Du; Haian Fu; James P Snyder; Aiming Sun
Journal:  Bioorg Med Chem Lett       Date:  2008-08-14       Impact factor: 2.823

Review 8.  Applications of Palladium-Catalyzed C-N Cross-Coupling Reactions.

Authors:  Paula Ruiz-Castillo; Stephen L Buchwald
Journal:  Chem Rev       Date:  2016-09-30       Impact factor: 60.622

Review 9.  Discovery and development of heat shock protein 90 inhibitors.

Authors:  Tony Taldone; Weilin Sun; Gabriela Chiosis
Journal:  Bioorg Med Chem       Date:  2008-11-06       Impact factor: 3.641

Review 10.  Benzisoxazole: a privileged scaffold for medicinal chemistry.

Authors:  K P Rakesh; C S Shantharam; M B Sridhara; H M Manukumar; Hua-Li Qin
Journal:  Medchemcomm       Date:  2017-10-31       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.